Greenstar Biosciences is entering the psychedelics space via its acquisition of Eleusian Biosciences Corp.

With the closing of its second tranche, Red Light Holland has now raised $3,830,529 in its current private placement.

Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer’s.

Once upon a time, I was a one-hit wonder. Just one inhale would render a dull day into one that was endlessly entertaining.

Champignon Brands closes on a $15 million financing to expand its clinical psychedelics research programs.

Revive expands on its psychedelics research aimed at addiction treatment.

Cannabis supporters in Arkansas can now accept electronic signatures in their campaign to put the legalization question on November’s ballot.

As rumors swirl about Compass Pathways going public, this could become the first psychedelics Unicorn.

Numinus becomes the first publicly traded company in Canada to obtain such licensing for psychedelics research.